Image

Blood Flow Restriction Training in Knee Arthropathy

Blood Flow Restriction Training in Knee Arthropathy

Recruiting
18-60 years
All
Phase N/A

Powered by AI

Overview

Arthrogenic muscle inhibition (AMI) is the key neurophysiological cause of impeding quadriceps activation following anterior cruciate ligament reconstruction (ACLR). Blood flow restriction training (BFRT) may induce neuroplasticity whereas the neurophysiological responses remain uncertain. In this study, we aimed to explore the effects of constant pressure blood flow restriction training (CP-BFRT) on neurophysiological responses and physical function. Patients will receive the same standardized progressive physical rehabilitation for 2 weeks after the surgery and then start the BRFT or sham BRFT intervention for the following 12 weeks.

Eligibility

Inclusion Criteria:

  1. Knee arthroscopy;
  2. Age 18-60 years;
  3. Ability to provide informed consent;
  4. Availability for follow-up assessments;
  5. Written informed consent.

Exclusion Criteria:

  1. Neurological disorders affecting lower extremity function;
  2. Vascular disease or coagulopathy;
  3. Contralateral knee pathology;
  4. Previous knee surgery;
  5. inability to comply with rehabilitation protocols;
  6. pregnancy.

Study details
    Knee Arthroscopic Surgery
    Arthrogenic Muscle Inhibition
    Quadriceps Muscle Weakness

NCT07837154

Yuxiu Ji

31 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.